Veritas Therapeutics
Company Information
Veritas Therapeutics currently presents itself as a biotechnology company developing diagnostic and therapeutic technologies based on FGL2 biology for autoimmune disease. The company website emphasizes platform development rather than a broad commercial portfolio. Its positioning appears focused on translational research and the use of FGL2-based approaches in immune-mediated conditions.
Industry Focus and Technologies
Biotechnology, autoimmune disease research, diagnostic development, therapeutic platform development, immunology, translational medicine.
Location
Toronto, Ontario, Canada
Company Size and Stage
Products, Platforms or Focus Areas
FGL2-based diagnostic technologies, FGL2-based therapeutic approaches, and platform work directed toward autoimmune disease applications.